JP2024525822A5 - - Google Patents
Info
- Publication number
- JP2024525822A5 JP2024525822A5 JP2024502130A JP2024502130A JP2024525822A5 JP 2024525822 A5 JP2024525822 A5 JP 2024525822A5 JP 2024502130 A JP2024502130 A JP 2024502130A JP 2024502130 A JP2024502130 A JP 2024502130A JP 2024525822 A5 JP2024525822 A5 JP 2024525822A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- antibody
- antigen
- binding fragment
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221686P | 2021-07-14 | 2021-07-14 | |
| US63/221,686 | 2021-07-14 | ||
| PCT/CA2022/051093 WO2023283736A1 (en) | 2021-07-14 | 2022-07-13 | Homologous dimerization peptides and antibodies comprising the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525822A JP2024525822A (ja) | 2024-07-12 |
| JP2024525822A5 true JP2024525822A5 (https=) | 2025-07-23 |
Family
ID=84918869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502130A Pending JP2024525822A (ja) | 2021-07-14 | 2022-07-13 | 相同二量体化ペプチド及びそれを含む抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240336696A1 (https=) |
| EP (1) | EP4370548A4 (https=) |
| JP (1) | JP2024525822A (https=) |
| KR (1) | KR20240035558A (https=) |
| CN (1) | CN117980330A (https=) |
| CA (1) | CA3225902A1 (https=) |
| WO (1) | WO2023283736A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024152113A1 (en) * | 2023-01-18 | 2024-07-25 | Morgan Alton C | Antibodies and antigen binding fragments coupled to homologous dimerization (hd) peptides for the prevention and treatment of infectious disease |
| WO2024152112A1 (en) * | 2023-01-18 | 2024-07-25 | Morgan Alton C | G protein-coupled receptor (gpcr) antibodies coupled to homologous dimerization (hd) peptides |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7569674B2 (en) * | 1998-05-04 | 2009-08-04 | Innexus Biotechnology International Limited | Autophilic antibodies |
| US20240124889A1 (en) * | 2019-05-07 | 2024-04-18 | Voyager Therapeutics, Inc. | Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation |
-
2022
- 2022-07-13 WO PCT/CA2022/051093 patent/WO2023283736A1/en not_active Ceased
- 2022-07-13 KR KR1020247005067A patent/KR20240035558A/ko active Pending
- 2022-07-13 CA CA3225902A patent/CA3225902A1/en active Pending
- 2022-07-13 US US18/579,715 patent/US20240336696A1/en active Pending
- 2022-07-13 CN CN202280062021.9A patent/CN117980330A/zh active Pending
- 2022-07-13 EP EP22840904.1A patent/EP4370548A4/en active Pending
- 2022-07-13 JP JP2024502130A patent/JP2024525822A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7140861B2 (ja) | ヘテロ二量体多重特異性抗体フォーマット | |
| JP6860601B2 (ja) | 改変した抗体組成物、それを作製および使用する方法 | |
| Adams et al. | Generating improved single-chain Fv molecules for tumor targeting | |
| IL302894A (en) | Tumor-specific claudin 18.2 antibody-drug conjugates | |
| KR102771043B1 (ko) | 적어도 cd3 및 hsa를 표적화하는 헤테로-이량체 다중 특이적 항체 포맷 | |
| KR20070084069A (ko) | Ｔｎｆｒ1에 대한 단일 도메인 항체 및 이의 사용 방법 | |
| JP2006523090A (ja) | リガンドに、そしてリガンド受容体に特異的な二重特異性単一ドメイン抗体 | |
| US20220332757A1 (en) | Split intein and preparation method for recombinant polypeptide using the same | |
| Simmons et al. | Dimerisation strategies for shark IgNAR single domain antibody fragments | |
| JP2010518062A (ja) | 血清アルブミンに対する抗体単一可変ドメイン | |
| JPH08505761A (ja) | 組換え特異的結合タンパク質 | |
| TW201204831A (en) | Dual variable domain immunoglobulins and uses thereof | |
| KR20220111308A (ko) | 인간화 cldn18.2 항체 | |
| CN118667019A (zh) | 针对人tim-3的单克隆抗体 | |
| JP2005528914A5 (https=) | ||
| US20240034783A1 (en) | Tumor-specific claudin 18.2 antibodies | |
| AU2015364687A1 (en) | Intercalated single-chain variable fragments | |
| KR20200015505A (ko) | 신규 항 hsa 항체 | |
| JP2024525822A5 (https=) | ||
| TW202434888A (zh) | 用於偵測及測定包括生物流體在內之流體中之蛋白質結構及穩定性的方法 | |
| CN106243223A (zh) | 抗人pdl1抗体及其用途 | |
| CN119285776A (zh) | 抗人tigit单克隆抗体tigit-m011或其功能性片段及其应用 | |
| IL301926A (en) | Antigen binding domain with reduced clipping rate | |
| WO2024225446A1 (ja) | 新規なＮａｖ１．７モノクローナル抗体を含む医薬組成物 | |
| CN121712805A (zh) | Ch3结构域变体或包含该ch3结构域变体的双特异性抗体 |